Quarterly Metrics: Quick and Current Ratios for Perspective Therapeutics Inc (CATX)

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

As of close of business last night, Perspective Therapeutics Inc’s stock clocked out at $1.76, up 1.15% from its previous closing price of $1.74. In other words, the price has increased by $1.15 from its previous closing price. On the day, 6.68 million shares were traded. CATX stock price reached its highest trading level at $1.78 during the session, while it also had its lowest trading level at $1.71.


To gain a deeper understanding of CATX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.55 and its Current Ratio is at 2.67. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Lantheus Alpha Therapy, LLC bought 60,431,039 shares for $0.95 per share. The transaction valued at 57,409,487 led to the insider holds 116,773,394 shares of the business.

Williamson Robert F III bought 127,206 shares of CATX for $90,710 on Jan 30 ’24. The Director now owns 338,761 shares after completing the transaction at $0.71 per share. On Jan 29 ’24, another insider, Williamson Robert F III, who serves as the Director of the company, bought 25,266 shares for $0.64 each. As a result, the insider paid 16,170 and bolstered with 211,555 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 1032972096 and an Enterprise Value of 1026285120. For the stock, the TTM Price-to-Sale (P/S) ratio is 116.85 while its Price-to-Book (P/B) ratio in mrq is 5.00. Its current Enterprise Value per Revenue stands at 715.68 whereas that against EBITDA is -25.683.

Stock Price History:

The Beta on a monthly basis for CATX is 1.49, which has changed by 2.911111 over the last 52 weeks, in comparison to a change of 0.26159418 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $1.90, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 23.97%, while the 200-Day Moving Average is calculated to be 156.55%.

Shares Statistics:

It appears that CATX traded 4.54M shares on average per day over the past three months and 5076950 shares per day over the past ten days. A total of 586.92M shares are outstanding, with a floating share count of 466.28M. Insiders hold about 20.55% of the company’s shares, while institutions hold 17.41% stake in the company. Shares short for CATX as of 1714435200 were 13594041 with a Short Ratio of 3.00, compared to 1711584000 on 8092736. Therefore, it implies a Short% of Shares Outstanding of 13594041 and a Short% of Float of 2.91.

Most Popular

[the_ad id="945"]